Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $2.9484 per EA under NDC 31722029730. Its NADAC has been published 22 times since Jan 28, 2026.
Strength
400 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722029730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212975On Market Since
4/14/2025
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 22 times since Jan 28, 2026, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $2.9484 (Jun 17, 2026) |
| 52-week high | $3.2150 |
| 52-week low | $2.9484 |
| Median price | $3.1868 |
| Average price | $3.1171 |
| Largest weekly change | -5.5% (Apr 22, 2026) |
| Weeks tracked | 22 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the IMATINIB MESYLATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $2.9484 per EA (NDC 31722029730), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has declined 7.5%. It has been tracked across 22 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Jan 28, 2026, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $2.9484 (Jun 17, 2026) to a high of $3.2150 (Mar 11, 2026), with a median of $3.1868 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IMATINIB MESYLATE 400 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 31722029730) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification